Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.46M Buy
11,135
+7,774
+231% +$1.9M 0.01% 607
2025
Q4
$852K Sell
3,361
-5,355
-61% -$1.34M ﹤0.01% 910
2025
Q3
$2.16M Buy
8,716
+5,233
+150% +$1.25M 0.01% 710
2025
Q2
$837K Sell
3,483
-733
-17% -$171K ﹤0.01% 486
2025
Q1
$956K Sell
4,216
-6,752
-62% -$1.49M ﹤0.01% 525
2024
Q4
$2.25M Sell
10,968
-4,773
-30% -$1.05M 0.01% 432
2024
Q3
$3.82M Sell
15,741
-6,212
-28% -$1.45M 0.02% 418
2024
Q2
$4.82M Sell
21,953
-67,161
-75% -$14.6M 0.03% 363
2024
Q1
$20M Sell
89,114
-12,870
-13% -$2.9M 0.1% 152
2023
Q4
$22.4M Sell
101,984
-22,751
-18% -$4.81M 0.13% 127
2023
Q3
$27.4M Buy
124,735
+7,454
+6% +$1.69M 0.17% 104
2023
Q2
$26.4M Sell
117,281
-12,951
-10% -$2.59M 0.16% 108
2023
Q1
$24.9M Buy
130,232
+2,636
+2% +$509K 0.15% 115
2022
Q4
$23.6M Sell
127,596
-34,152
-21% -$6M 0.13% 142
2022
Q3
$26.9M Buy
161,748
+2,390
+1% +$486K 0.14% 126
2022
Q2
$32.9M Buy
159,358
+344
+0.2% +$77.6K 0.14% 138
2022
Q1
$38.4M Buy
159,014
+36,293
+30% +$8.41M 0.16% 112
2021
Q4
$29.9M Buy
122,721
+9,543
+8% +$2.18M 0.17% 102
2021
Q3
$23.1M Buy
113,178
+5,395
+5% +$1.15M 0.13% 120
2021
Q2
$22.2M Buy
107,783
+51,884
+93% +$10.4M 0.14% 122
2021
Q1
$10.6M Buy
55,899
+6,668
+14% +$1.24M 0.09% 157
2020
Q4
$9.33M Buy
49,231
+27,966
+132% +$5.22M 0.08% 129
2020
Q3
$3.75M Buy
+21,265
New +$3.4M 0.05% 167
2019
Q1
Sell
-8,726
Closed -$932K 486
2018
Q4
$932K Buy
+8,726
New +$974K 0.01% 335
2018
Q3
Sell
-5,290
Closed -$556K 468
2018
Q2
$556K Sell
5,290
-4,770
-47% -$480K 0.01% 334
2018
Q1
$939K Buy
+10,060
New +$915K 0.01% 273
2015
Q4
Sell
-6,505
Closed -$423K 399
2015
Q3
$423K Buy
+6,505
New +$430K 0.01% 353

Other funds holding STE

Ray Dalio's STE Position: Q1 2026 in Review

Ray Dalio increased its Steris (STE) stake by 231% in Q1 2026, buying an estimated $1.9M and bringing the position to 11,135 shares worth $2.46M. The position accounts for 0.01% of the portfolio, ranked #607.

Ray Dalio first reported a position in STE in Q3 2015 and has held it in 27 quarters since. The position peaked at $38.4M in Q1 2022. 843 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Ray Dalio held 11,135 shares of Steris worth $2.46M as of Q1 2026.
  • Ray Dalio bought 7,774 Steris shares in Q1 2026, an estimated $1.9M.
  • Steris made up 0.01% of Ray Dalio's portfolio in Q1 2026, its #607 holding.
  • Ray Dalio first reported a position in Steris in Q3 2015 and has held it in 27 quarters since.
  • Ray Dalio's Steris position peaked at $38.4M in Q1 2022.
  • 843 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.